The H 3 K 9 dimethyltransferases EHMT 1 / 2 protect against pathological cardiac hypertrophy

[1]  Dean Y. Li,et al.  Epigenetic response to environmental stress: Assembly of BRG1-G9a/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed hearts. , 2016, Biochimica et biophysica acta.

[2]  Li Wang,et al.  Perinuclear Anchoring of H3K9-Methylated Chromatin Stabilizes Induced Cell Fate in C. elegans Embryos , 2015, Cell.

[3]  F. Neumann,et al.  Cardiac Myocyte De Novo DNA Methyltransferases 3a/3b Are Dispensable for Cardiac Function and Remodeling after Chronic Pressure Overload in Mice , 2015, PloS one.

[4]  Jens R. Nyengaard,et al.  Dynamics of Cell Generation and Turnover in the Human Heart , 2015, Cell.

[5]  Gregory M. Fomovsky,et al.  Transcriptional reversion of cardiac myocyte fate during mammalian cardiac regeneration. , 2014, Circulation research.

[6]  V. Beneš,et al.  Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease , 2014, Nature Communications.

[7]  C. Tse,et al.  Discovery and development of potent and selective inhibitors of histone methyltransferase g9a. , 2014, ACS medicinal chemistry letters.

[8]  S. Kajimura,et al.  EHMT1 controls brown adipose cell fate and thermogenesis through the PRDM16 complex , 2013, Nature.

[9]  R. Schwartz,et al.  Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis , 2013, Mechanisms of Development.

[10]  J. Backs,et al.  HDAC4 controls histone methylation in response to elevated cardiac load. , 2013, Journal of Clinical Investigation.

[11]  K. Mikoshiba,et al.  Mutual antagonism between IP3RII and miRNA-133a regulates calcium signals and cardiac hypertrophy , 2012, The Journal of cell biology.

[12]  Weiqun Peng,et al.  Histone H3K9 methyltransferase G9a represses PPARγ expression and adipogenesis , 2012, The EMBO journal.

[13]  D. Sin.  Faculty Opinions recommendation of Projections of global mortality and burden of disease from 2002 to 2030. , 2012 .

[14]  Alexander R. Pico,et al.  Dynamic and Coordinated Epigenetic Regulation of Developmental Transitions in the Cardiac Lineage , 2012, Cell.

[15]  E. Greer,et al.  Histone methylation: a dynamic mark in health, disease and inheritance , 2012, Nature Reviews Genetics.

[16]  W. K. Kok,et al.  Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation , 2012, Proceedings of the National Academy of Sciences.

[17]  J. Seidman,et al.  Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis , 2011, Nature Genetics.

[18]  Peter A. DiMaggio,et al.  A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. , 2011, Nature chemical biology.

[19]  Y. Shinkai,et al.  H3K9 methyltransferase G9a and the related molecule GLP. , 2011, Genes & development.

[20]  Guillaume J. Filion,et al.  Systematic Protein Location Mapping Reveals Five Principal Chromatin Types in Drosophila Cells , 2010, Cell.

[21]  J. McMullen,et al.  Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. , 2010, Pharmacology & therapeutics.

[22]  K. Mikoshiba,et al.  The IP3 Receptor Regulates Cardiac Hypertrophy in Response to Select Stimuli , 2010, Circulation research.

[23]  S. Mullaly,et al.  Activating and inhibitory functions for the histone lysine methyltransferase G9a in T helper cell differentiation and function , 2010, The Journal of experimental medicine.

[24]  M. Latronico,et al.  microRNAs in heart disease: putative novel therapeutic targets? , 2010, European heart journal.

[25]  P. Greengard,et al.  Control of Cognition and Adaptive Behavior by the GLP/G9a Epigenetic Suppressor Complex , 2009, Neuron.

[26]  D. Gilbert,et al.  G9a selectively represses a class of late-replicating genes at the nuclear periphery , 2009, Proceedings of the National Academy of Sciences.

[27]  K. Mikoshiba,et al.  Endothelin-1-stimulated InsP3-induced Ca2+ release is a nexus for hypertrophic signaling in cardiac myocytes. , 2009, Molecular cell.

[28]  Samuel Bernard,et al.  Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.

[29]  M. Reth,et al.  Functional Analysis of Histone Methyltransferase G9a in B and T Lymphocytes1 , 2008, The Journal of Immunology.

[30]  L. Wessels,et al.  Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions , 2008, Nature.

[31]  Y. Shinkai,et al.  Functional dynamics of H3K9 methylation during meiotic prophase progression , 2007, The EMBO journal.

[32]  Alex Magee,et al.  Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. , 2006, American journal of human genetics.

[33]  J. Molkentin,et al.  Regulation of cardiac hypertrophy by intracellular signalling pathways , 2006, Nature Reviews Molecular Cell Biology.

[34]  Yang Shi,et al.  Reversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases , 2006, Cell.

[35]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[36]  Tsutomu Ohta,et al.  Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. , 2005, Genes & development.

[37]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[38]  Michael D. Schneider,et al.  Sizing up the heart: development redux in disease. , 2003, Genes & development.

[39]  H. Kato,et al.  G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. , 2002, Genes & development.

[40]  M. Crackower,et al.  Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein , 2001, Circulation research.

[41]  L. Leinwand,et al.  Myosin heavy chain isoform expression in the failing and nonfailing human heart. , 2000, Circulation research.

[42]  M. Soonpaa,et al.  Survey of studies examining mammalian cardiomyocyte DNA synthesis. , 1998, Circulation research.

[43]  G. Lopaschuk,et al.  Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. , 1994, The American journal of physiology.

[44]  K. Chien,et al.  Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. , 1990, The Journal of biological chemistry.

[45]  S. Kajimura,et al.  EHMT 1 controls brown adipose cell fate and thermogenesis through the PRDM 16 complex , 2013 .

[46]  Y. Shinkai,et al.  H 3 K 9 methyltransferase G 9 a and the related molecule GLP , 2011 .

[47]  E. Olson,et al.  The many roles of histone deacetylases in development and physiology: implications for disease and therapy , 2009, Nature Reviews Genetics.

[48]  A. Aszódi,et al.  H3K27me3 forms BLOCs over silent genes and intergenic regions and specifies a histone banding pattern on a mouse autosomal chromosome. , 2009, Genome research.

[49]  G. Dorn,et al.  Cytoplasmic signaling pathways that regulate cardiac hypertrophy. , 2001, Annual review of physiology.